基本信息
文件名称:Tranexamic-acid-13C6-Cyclocapron-sup-13-sup-C-sub-6-sub-生命科学试剂-MCE.pdf
文件大小:658.01 KB
总页数:2 页
更新时间:2025-05-20
总字数:约3.52千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

Tranexamicacid-13C6

Cat.No.:HY-B0149S2

Synonyms:Cyclocapron-13C6

分?式:C???C?H?NO?

分?量:153.09

作?靶点:Isotope-LabeledCompounds;MMP;Mitophagy;IGF-1R;

AMPK

作?通路:Others;MetabolicEnzyme/Protease;Autophagy;Protein

TyrosineKinase/RTK;Epigenetics;PI3K/Akt/mTOR

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性Tranexamicacid-13C6(Cyclocapron-13C6)是13C标记的Tranexamicacid.Tranexamicacid

(cyclocapron),赖氨酸的环类似物,是?种具有?服活性的抗纤维蛋?溶解剂。Tranexamicacid减轻严重创

伤的影响,抑制尿激酶型纤溶酶原激活剂,改善?性皱纹,可?于??的研究[1][2][3][4][5]。

体外研究Stableheavyisotopesofhydrogen,carbon,andotherelementshavebeenincorporatedintodrugmolecules,

largelyastracersforquantitationduringthedrugdevelopmentprocess.Deuterationhasgainedattention

becauseofitspotentialtoaffectthepharmacokineticandmetabolicprofilesofdrugs.

REFERENCES

[1].RussakEM,etal.ImpactofDeuteriumSubstitutiononthePharmacokineticsofPharmaceuticals.AnnPharmacother.2019;53(2):211-

216.

[2].PrudovskyI,etal.TranexamicacidsuppressesthereleaseofmitochondrialDNA,protectstheendothelialmonolayerandenh